Advertisement

Effect of Hyperthermia on Human Natural Killer Cells

  • M. Onsrud
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 109)

Abstract

Natural killer (NK) cells, a subset of lymphocytes, have the ability preferentially to kill virus-infected cells and certain tumor cells in vitro (Herberman et al. 1979). NK cells have been proposed to represent a first level defense mechanism against tumor development and tumor spread in vivo (Herberman 1981; Pollack and Hallenbeck 1982). A correlation between defective NK activity and an increased incidence of malignant disease both in man and in mice supports this concept (Haliotis et al. 1980; Talmadge et al. 1980).

Keywords

Natural Killer Natural Killer Cell Natural Killer Cell Activity Thermal Sensitivity Natural Killer Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Azocar J, Yunis EJ, Essex M (1982) Sensitivity of human natural killer cells to hyperthermia. Lancet I: 16–17CrossRefGoogle Scholar
  2. Brunda MJ, Herberman RB, Holden HT (1980) Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 124: 2682–2687PubMedGoogle Scholar
  3. Cantell K, Hirvonen S (1978) Large scale production in human leucocyte interferon containing 108 units per ml. J Gen Virol 39: 541–543PubMedCrossRefGoogle Scholar
  4. Haliotis T, Roder J, Klein M, Ortaldo J, Fauci AS, Herberman RB (1980) Chediak-Higashi gene in humans. I. Impairment of natural killer function. J Exp Med 151: 1039–1048PubMedCrossRefGoogle Scholar
  5. Herberman RB (1981) Significance of natural killer cells in cancer research. Human Lymph Diff 1: 63–76Google Scholar
  6. Herberman RB, Djeu JY, Kay D, Ortaldo JR, Riccardi C, Bonnard GD, Holden GT, Fagnani R, Santoni A, Puccetti P (1979) Natural killer cells: characteristics and regulation of activity. Immunol Rev 44: 43–70PubMedCrossRefGoogle Scholar
  7. Hopwood LE, Zeevi A, Doquesnoy R (1984) Response of human peripheral lymphocytes to hyperthermia (meeting abstr). 32nd Annual meeting of the Radiation Research Society, 25–29 March 1984, Orlando, Florida, p 51Google Scholar
  8. Onsrud M, Thorsby E (1981) Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand J Immunol 13: 573–579PubMedCrossRefGoogle Scholar
  9. Pichler WJ, Broder S (1981) In vitro functions of human T cells expressing Fc-IgG or Fc-IgM receptors. Immunol Rev 56: 163–197PubMedCrossRefGoogle Scholar
  10. Pollack SB, Hallenbeck LA (1982) In vivo reduction of NK activity with anti-NK 1 serum: direct evaluation of NK cells in tumor clearance. Int J Cancer 29: 203–207PubMedCrossRefGoogle Scholar
  11. Saksela E, Timonen T, Cantell K (1979) Human natural killer cell activity is augmented by interferon via recruitment of “pre-NK” cells. Scand J Immunol 10: 257–266PubMedCrossRefGoogle Scholar
  12. Schechter M, Stowe SM, Moroson H (1978) Effects of hyperthermia on primary and metastatic tumor growth and host immune response in rats. Cancer Res 38: 498–502PubMedGoogle Scholar
  13. Shen RN, Shidnia H, Brahmi Z, Hornback NB (1985) Decreased lung metastases and higher natural killer cell activity by whole-body hyperthermia in Lewis lung carcinoma and B16 melanoma (meeting abstr). International Clinical Hyperthermia Society meeting, 21–26 April 1985, Charleston, South CarolinaGoogle Scholar
  14. Talmadge JE, Meyers KM, Prieur DY, Starkey JR (1980) Role of NK cells in tumor growth and metastasis in beige mice. Nature 284: 622–624PubMedCrossRefGoogle Scholar
  15. Yerushalmi A (1976) Influence on metastatic spread of whole body or local tumor hyperthermia. Eur J Cancer 12: 455–463PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • M. Onsrud
    • 1
  1. 1.KvinneklinikkenRegionsykehusetTrondheimNorway

Personalised recommendations